Chardonnay Marc and Vascular Response
Part of paid clinical trials in Davis, California.
- Sponsor
- University of California, Davis
- Study ID
- NCT05545865
- Status
- Recruiting
Conditions
- Cardiovascular Diseases
- Oxidative Stress
- Vascular Dilation
Eligibility Criteria
- Sex
- MALE
- Age
- 30 Years - 50 Years
- Healthy Volunteers
- Accepted
Interventions
- Low Flavanol Cocoa Powder — OTHERMeasure the response 2 and 6 hours post low flavanol cocoa intake
- High Flavanol Cocoa Powder — OTHERMeasure the response 2 and 6 hours post high flavanol cocoa intake
- Vine to Bar Chocolate - 2 servings — OTHERMeasure the response 2 and 6 hours post chocolate intake
- Vine to Bar Chocolate - 1 serving — OTHERMeasure the response 2 and 6 hours post chocolate intake
- Vine to Bar Chocolate covered almonds — OTHERMeasure the response 2 and 6 hours post chocolate covered almond intake
Study Details
This study aims to obtain data on the potential influence of Vine to Bar product(s) containing Chardonnay marc on cardiometabolic health. These initial studies will inform the design and timing of data collection for future dietary intervention trials that will examine the influence of Chardonnay marc intake on outcomes/biomarkers of both cardiometabolic health and the gut microbiome. This includes collecting data on the potential differences in response to the products based on the unique food matrix for each of the products that will be tested. Moreover, as there is a paucity of data on the influence of cocoa flavanol intake on vascular function beyond 4 hours post intake, the response of the selected outcomes will be assessed after 6 hours of flavanol intake. This is a time point that captures the increased circulating presence of microbial derived flavanol metabolites.
Key Dates
- Start date
- Sep 1, 2022
- Status verified
- Feb 2026
- Primary completion
- Aug 24, 2026
- Completion
- Aug 24, 2026
Study Design
- Enrollment
- 5 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- OTHER
Arms
- Placebo Comparator: Low Flavanol Cocoa Powder12 g of Low Flavanol Cocoa Powder (30 mg of cocoa flavanols) provided as a beverage mixed in water
- Experimental: High Flavanol Cocoa PowderHigh Flavanol Cocoa Powder (435 mg of flavanols) will be provided as a beverage mixed in water.
- Experimental: Two Servings of Vine to Bar ChocolateTwo servings (60g, 6 pieces) of Vine to Bar Chocolate providing both cocoa flavanols and Chardonnay marc.
- Experimental: One Serving of Vine to Bar ChocolateA single serving (30g, 3 pieces) of Vine to Bar Chocolate providing both cocoa flavanols and Chardonnay marc.
- Experimental: Vine to Bar Chocolate covered Almonds11 pieces (45g) of Vine to Bar Chocolate providing both cocoa flavanols and Chardonnay marc, with almonds
Primary Outcome Measure
Framingham Reactive Hyperemia Index (fRHI) [ Time Frame: 6 hours ]
Central Contacts
- Roberta R Holt5304005952
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Academic Surge, University of California, Davis | Davis | California | 95616 |
Find similar trials in Davis, CA
Related Studies
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRRecruiting · Cardiac Dimensions, Inc. · Gilbert, Arizona
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older AdultsPHASE4 · Recruiting · Duke University · Birmingham, Alabama
- Secondhand Tobacco Smoke and Cardiovascular DiseasePHASE4 · Recruiting · University of California, San Francisco · San Francisco, California